Drug · DIN 02421208
ONRELTEA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 24, 2014; first marketed March 24, 2014.
- Drug Identification Number (DIN)
- 02421208
- Company (DIN owner)
- Galderma Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Brimonidine D11AX21
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRIMONIDINE (BRIMONIDINE TARTRATE) | 0.33 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 26, 2014: NOC 15339New Drug Submission (NDS)